HemaSphere (Jun 2022)
P1696: HEMOSTATIC ACTIVATION MARKERS AND SEROLOGICAL RESPONSE IN SUBJECTS RECEIVING ANTI-COVID-19 VACCINATION
- F. Schieppati,
- S. Gamba,
- E. Galimberti,
- L. Russo,
- C. Giaccherini,
- S. Bolognini,
- C. J. Tartari,
- C. Ticozzi,
- A. M. Palladino,
- O. C. Cretu,
- L. Barcella,
- M. Marchetti,
- A. Falanga
Affiliations
- F. Schieppati
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- S. Gamba
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- E. Galimberti
- 2 Medicine and Surgery, University of Milano Bicocca, Milano, Italy
- L. Russo
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- C. Giaccherini
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- S. Bolognini
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- C. J. Tartari
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- C. Ticozzi
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- A. M. Palladino
- 2 Medicine and Surgery, University of Milano Bicocca, Milano, Italy
- O. C. Cretu
- 2 Medicine and Surgery, University of Milano Bicocca, Milano, Italy
- L. Barcella
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- M. Marchetti
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- A. Falanga
- 1 Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo
- DOI
- https://doi.org/10.1097/01.HS9.0000849640.97953.ed
- Journal volume & issue
-
Vol. 6
pp. 1577 – 1578
Abstract
No abstracts available.